CDKN2A and diffuse large B-cell lymphoma: In our results, the frequency of MYD88L265P, PIM1, and CD79B mutations and CDKN2A/B loss was significantly higher in both PCNSL and PTL than in DLBCL NOS and PMLBL, which was consistent with previous studies.19, 34, 35